Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. The active compounds in marijuana, known as cannabinoids, interact with the body’s endocannabinoid system to produce therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. Inflammation in the brain is thought to contribute to the development and persistence of seizures.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Herb Collective

AUGUST 1, 2023

The cannabinoids found in Cannabis Indica have been shown to have a relaxing effect on the body, which causes a decrease in blood pressure. While the exact mechanisms behind this phenomenon are still being researched, the results are promising.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

United Patients Group

FEBRUARY 8, 2023

Natural opioids include opium or poppy seeds; synthetic ones were first developed in 1950s by German chemist Paul Janssen, who went on to found Janssen Pharmaceutica NV (now part of Johnson & Johnson). Cannabinoids may have potential in treating chronic pain. Cannabinoids may have potential in treating chronic pain.

Chronic Pain 81

Chronic Pain Cannabinoids Research and Development Patients 81

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

United Patients Group

OCTOBER 25, 2023

Medical marijuana’s therapeutic effects are primarily due to its active compounds, known as cannabinoids. The two primary cannabinoids are delta-9-tetrahydrocannabinol ( THC ) and cannabidiol ( CBD ). Can You Become Addicted to Medical Marijuana?

Marijuana 88

Marijuana Patients Research and Development Edibles 88

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. The two cannabinoids can also cause very different effects in other ways.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Veriheal

DECEMBER 8, 2023

The report is expected to touch on the following: The medical potential of cannabis and CBD for serious conditions like epilepsy The effects of delta-9 THC on brain development, and driving abilities Barriers to cannabis research in states where cannabis is illegal Recommendations on regulations and testing needed for more accurate cannabinoid level (..)

Recreational 101

Recreational Research and Development Epilepsy THC 101

Medicinal Marijuana Association

FEBRUARY 11, 2024

Endocannabinoid System Overview Understanding the endocannabinoid system is crucial for grasping how cannabinoids interact with your body to regulate various physiological functions and maintain balance. Cannabinoids such as CBD work by binding to specific receptors and influencing various physiological processes.

CBD 52

CBD Research and Development Topical Cannabinoids 52

TheAnswerPage

JULY 22, 2021

Some cannabinoid-based drugs have been approved by national drug administrations. Other than seizure disorders, what are the therapeutic indications for cannabinoid-based medicines that have been approved by a national drug administration? Research, Society and Development, [S. de; SILVA , A. ABREU , L. GONZAGA, R.

Research and Development 52

Research and Development Epilepsy Treatment Cannabinoids 52

Veriheal

JANUARY 18, 2023

In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. Confusion surrounding British CBD laws has thrust the cannabinoid into a legal gray area.

CBD 79

CBD Strains Research and Development Oil 79

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

United Patients Group

FEBRUARY 2, 2023

It’s made up of endocannabinoids and cannabinoid receptors, which work together to maintain homeostasis in the body by regulating things like mood, energy, appetite and sleep cycles. The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). antibiotics).

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.

CBD 99

CBD DEA Research and Development Hemp 99

United Patients Group

APRIL 24, 2023

In addition, cannabis might also help improve heart health by reducing inflammation around vessels; this reduces the risk of developing atherosclerosis (the hardening of arteries) or plaque buildup inside them. In addition to these potential side effects, some epilepsy medications have been linked with depression and suicidal thoughts.

Blood Pressure 52

Blood Pressure Sleep Cannabinoids Research and Development 52

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

CannaMD

AUGUST 19, 2020

Researchers with Microbiology and Molecular Biology Reviews elaborate: The term “cytokine storm” calls up vivid images of an immune system gone awry and an inflammatory response flaring out of control. Marijuana cannabinoid, CBD. ” And their alternative strategy of choice? CBD: Cytokine Storm Fighter.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

United Patients Group

APRIL 18, 2023

However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. The US federal government even owns a patent on cannabinoids for use as a neuroprotectant! Myth: Cannabis is just a drug. Cannabis is a plant. Click here to view.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Kind Meds (Cannabis Education Blog)

DECEMBER 1, 2023

In this blog post, we will explain everything you need to know about the top cannabinoids in cannabis and how they work together with other cannabis compounds to produce an ideal effect on your body. Learning more about other cannabinoids can help you select a cannabis strain that better meets your needs. What Is a Cannabinoid?

Cannabinoids 105

Cannabinoids Sleep THC Strains 105

Veriheal

MAY 17, 2023

As of 2021, just two Singaporeans with treatment-resistant epilepsy have been approved to use medicinal cannabis in the form of Epidiolex. However, cannabis is usually only considered as a last resort after all other treatment options have been exhausted.

Research and Development 83

Research and Development Medicine Treatment Epilepsy 83

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

SEPTEMBER 27, 2021

Individuals with this condition have to find ways to deal with the fact that their immune system is attacking the protective sheath of nerve fiber surrounding the nerve cells, putting the body in a state of imbalance that results in muscle spasms, paralysis, disrupted bladder function, mental changes, depression, and even epilepsy.

Treatment 98

Treatment Patients Access Research and Development 98

The Cannigma

FEBRUARY 21, 2021

They are making those moves,” said Jake Kuczeruk, vice president of business development at The Arcview Group, a cannabis investment, consulting, and research group. If the cultivators could develop a relationship with their customers, they could get a lot more brand loyalty,” Dr. Fisher explained. billion by 2024.

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

The Joint Blog

JULY 4, 2023

While people may primarily use it to induce a psychoactive effect, modern research has revealed its well-known therapeutic benefits. VPD (Vapor Pressure Deficit) is an important factor when growing cannabis, as it can significantly impact the plant’s growth and development. Did you know cannabis isn’t just for getting high?

Sleep 52

Sleep Research and Development Food Conditions 52